Consensus Rating1
Hold
Highest Price Target1
$40.00
Lowest Price Target1
$7.00
Consensus Price Target1
$15.29

Teladoc Health Analyst Ratings and Price Targets | NYSE:TDOC | Benzinga

Teladoc Health Inc has a consensus price target of $15.29 based on the ratings of 29 analysts. The high is $40 issued by DA Davidson on October 25, 2022. The low is $7 issued by B of A Securities on May 28, 2025. The 3 most-recent analyst ratings were released by B of A Securities, Truist Securities, and Wells Fargo on May 28, 2025, May 27, 2025, and May 8, 2025, respectively. With an average price target of $8 between B of A Securities, Truist Securities, and Wells Fargo, there's an implied 14.70% upside for Teladoc Health Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
2
2
Feb
1
Mar
2
Apr
2
2
May
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
2.8
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

B of A Securities
Truist Securities
Wells Fargo
Canaccord Genuity
Goldman Sachs

1calculated from analyst ratings

Analyst Ratings for Teladoc Health

Buy NowGet Alert
05/28/2025Buy Now0.36%B of A Securities
Allen Lutz51%
$8 → $7MaintainsNeutralGet Alert
05/27/2025Buy Now29.03%Truist Securities
Jailendra Singh34%
$10 → $9MaintainsHoldGet Alert
05/08/2025Buy Now14.7%Wells Fargo
Stan Berenshteyn41%
$10 → $8MaintainsEqual-WeightGet Alert
05/01/2025Buy Now72.04%Canaccord Genuity
Richard Close43%
$14 → $12MaintainsBuyGet Alert
05/01/2025Buy Now43.37%Goldman Sachs
David Roman40%
$13 → $10MaintainsBuyGet Alert
05/01/2025Buy Now14.7%Stifel
David Grossman64%
$9 → $8MaintainsHoldGet Alert
05/01/2025Buy Now0.36%Evercore ISI Group
Elizabeth Anderson45%
$8 → $7MaintainsIn-LineGet Alert
05/01/2025Buy NowNeedham
Ryan MacDonald60%
ReiteratesHold → HoldGet Alert
04/25/2025Buy Now25.45%Citigroup
Daniel Grosslight39%
$11 → $8.75MaintainsNeutralGet Alert
04/21/2025Buy Now14.7%Jefferies
Glen Santangelo49%
$10 → $8MaintainsHoldGet Alert
04/11/2025Buy Now14.7%B of A Securities
Allen Lutz51%
$9.5 → $8MaintainsNeutralGet Alert
03/03/2025Buy Now86.38%Goldman Sachs
David Roman40%
$16 → $13MaintainsBuyGet Alert
02/27/2025Buy NowNeedham
Ryan MacDonald60%
ReiteratesHold → HoldGet Alert
02/27/2025Buy Now72.04%Piper Sandler
Jessica Tassan35%
$13 → $12MaintainsOverweightGet Alert
02/18/2025Buy Now129.39%Goldman Sachs
David Roman40%
$14 → $16MaintainsBuyGet Alert
02/12/2025Buy Now93.55%B of A Securities
Allen Lutz51%
$11.5 → $13.5MaintainsNeutralGet Alert
02/06/2025Buy Now64.87%B of A Securities
Allen Lutz51%
$10.5 → $11.5MaintainsNeutralGet Alert
01/24/2025Buy Now72.04%RBC Capital
Sean Dodge46%
$11 → $12MaintainsOutperformGet Alert
01/24/2025Buy Now72.04%Oppenheimer
Michael Wiederhorn60%
$14 → $12MaintainsOutperformGet Alert
12/04/2024Buy Now86.38%Piper Sandler
Jessica Tassan35%
$11 → $13ReiteratesOverweight → OverweightGet Alert
11/15/2024Buy Now100.72%Goldman Sachs
David Roman40%
→ $14Initiates → BuyGet Alert
11/01/2024Buy Now72.04%Deutsche Bank
George Hill61%
$10 → $12MaintainsHoldGet Alert
10/31/2024Buy Now72.04%Barclays
Steve Valiquette53%
$10 → $12MaintainsOverweightGet Alert
10/31/2024Buy Now14.7%TD Cowen
Charles Rhyee36%
$9 → $8MaintainsHoldGet Alert
10/09/2024Buy Now43.37%RBC Capital
Sean Dodge46%
$9 → $10MaintainsOutperformGet Alert
10/08/2024Buy Now29.03%Evercore ISI Group
Elizabeth Anderson45%
$8 → $9MaintainsIn-LineGet Alert
09/17/2024Buy Now43.37%Jefferies
Glen Santangelo49%
$8 → $10MaintainsHoldGet Alert
08/26/2024Buy Now29.03%JP Morgan
Lisa Gill56%
$16 → $9MaintainsNeutralGet Alert
08/20/2024Buy Now43.37%Cantor Fitzgerald
Sarah James50%
$10 → $10ReiteratesOverweight → OverweightGet Alert
08/06/2024Buy Now43.37%Piper Sandler
Jessica Tassan35%
$25 → $10MaintainsOverweightGet Alert
08/02/2024Buy Now43.37%Deutsche Bank
George Hill61%
$15 → $10MaintainsHoldGet Alert
08/02/2024Buy Now43.37%Truist Securities
Jailendra Singh34%
$15 → $10MaintainsHoldGet Alert
08/01/2024Buy NowNeedham
Ryan MacDonald60%
Reiterates → HoldGet Alert
08/01/2024Buy Now29.03%TD Cowen
Charles Rhyee36%
$15 → $9MaintainsHoldGet Alert
08/01/2024Buy Now29.03%RBC Capital
Sean Dodge46%
$18 → $9MaintainsOutperformGet Alert
08/01/2024Buy Now43.37%Barclays
Steve Valiquette53%
$20 → $10MaintainsOverweightGet Alert
08/01/2024Buy Now29.03%Stifel
David Grossman64%
$16 → $9MaintainsHoldGet Alert
08/01/2024Buy Now14.7%DA Davidson
Gil Luria62%
$12 → $8MaintainsNeutralGet Alert
08/01/2024Buy Now143.73%Canaccord Genuity
Richard Close43%
$25 → $17MaintainsBuyGet Alert
08/01/2024Buy Now143.73%Oppenheimer
Michael Wiederhorn60%
$21 → $17MaintainsOutperformGet Alert
07/09/2024Buy Now43.37%Evercore ISI Group
Elizabeth Anderson45%
$14 → $10MaintainsIn-LineGet Alert
05/21/2024Buy Now129.39%JP Morgan
Lisa Gill56%
$19 → $16MaintainsNeutralGet Alert
05/20/2024Buy Now100.72%Jefferies
Glen Santangelo49%
$16 → $14MaintainsHoldGet Alert
05/14/2024Buy Now93.55%B of A Securities
Allen Lutz51%
$16.5 → $13.5MaintainsNeutralGet Alert
04/29/2024Buy Now115.05%Wells Fargo
Stephen Baxter53%
$17 → $15MaintainsEqual-WeightGet Alert
04/26/2024Buy Now201.08%Oppenheimer
Michael Wiederhorn60%
$26 → $21MaintainsOutperformGet Alert
04/26/2024Buy Now115.05%TD Cowen
Charles Rhyee36%
$16 → $15MaintainsHoldGet Alert
04/26/2024Buy Now100.72%Evercore ISI Group$15 → $14MaintainsIn-LineGet Alert
04/26/2024Buy Now158.06%RBC Capital
Sean Dodge46%
$25 → $18MaintainsOutperformGet Alert
04/26/2024Buy Now129.39%Stifel
David Grossman64%
$21 → $16MaintainsHoldGet Alert
04/26/2024Buy Now186.74%Barclays
Steve Valiquette53%
$25 → $20MaintainsOverweightGet Alert
04/26/2024Buy Now258.42%Canaccord Genuity
Richard Close43%
$28 → $25MaintainsBuyGet Alert
04/26/2024Buy NowNeedham
Ryan MacDonald60%
Reiterates → HoldGet Alert
04/05/2024Buy NowNeedham
Ryan MacDonald60%
Reiterates → HoldGet Alert
03/06/2024Buy Now143.73%Truist Securities
Jailendra Singh34%
$23 → $17MaintainsHoldGet Alert
02/29/2024Buy Now215.41%Cantor Fitzgerald
Sarah James50%
→ $22Initiates → OverweightGet Alert
02/26/2024Buy Now143.73%Leerink Partners
Michael Cherny78%
→ $17Initiates → Market PerformGet Alert
02/21/2024Buy Now158.06%DA Davidson
Gil Luria62%
$22 → $18MaintainsNeutralGet Alert
02/21/2024Buy Now172.4%Citigroup
Daniel Grosslight39%
$21 → $19MaintainsNeutralGet Alert
02/21/2024Buy Now258.42%RBC Capital
Sean Dodge46%
$30 → $25MaintainsOutperformGet Alert
02/21/2024Buy Now258.42%Barclays
Steve Valiquette53%
$26 → $25MaintainsOverweightGet Alert
02/21/2024Buy Now258.42%Piper Sandler
Jessica Tassan35%
$30 → $25MaintainsOverweightGet Alert
02/21/2024Buy Now301.43%Canaccord Genuity
Richard Close43%
$34 → $28MaintainsBuyGet Alert
11/17/2023Buy Now172.4%JP Morgan
Lisa Gill56%
$33 → $19MaintainsNeutralGet Alert
10/25/2023Buy Now330.11%RBC Capital
Sean Dodge46%
$35 → $30MaintainsOutperformGet Alert
10/25/2023Buy Now272.76%Oppenheimer
Michael Wiederhorn60%
$35 → $26MaintainsOutperformGet Alert
10/23/2023Buy Now201.08%Citigroup
Daniel Grosslight39%
$29 → $21MaintainsNeutralGet Alert
10/20/2023Buy Now201.08%Citigroup
Daniel Grosslight39%
$29 → $21MaintainsNeutralGet Alert
09/25/2023Buy Now301.43%Truist Securities
Jailendra Singh34%
→ $28ReiteratesHold → HoldGet Alert
07/26/2023Buy Now301.43%Stephens & Co.
Jeff Garro37%
→ $28ReiteratesEqual-Weight → Equal-WeightGet Alert
07/26/2023Buy Now401.79%RBC Capital
Sean Dodge46%
→ $35ReiteratesOutperform → OutperformGet Alert
07/26/2023Buy Now315.77%Citigroup
Daniel Grosslight39%
$31 → $29MaintainsNeutralGet Alert
07/26/2023Buy Now287.1%Credit Suisse
Jonathan Yong65%
→ $27ReiteratesNeutral → NeutralGet Alert
04/28/2023Buy Now315.77%Deutsche Bank
George Hill61%
$27 → $29MaintainsHoldGet Alert
04/27/2023Buy Now344.44%Citigroup
Daniel Grosslight39%
$30 → $31MaintainsNeutralGet Alert
04/27/2023Buy Now401.79%RBC Capital
Sean Dodge46%
→ $35Reiterates → OutperformGet Alert
04/27/2023Buy Now287.1%Credit Suisse
Jonathan Yong65%
→ $27Reiterates → NeutralGet Alert
04/27/2023Buy Now315.77%Barclays
Steve Valiquette53%
$28 → $29MaintainsEqual-WeightGet Alert
04/12/2023Buy Now258.42%Stephens & Co.
Jeff Garro37%
→ $25Initiates → Equal-WeightGet Alert
03/10/2023Buy Now287.1%Credit Suisse
Jonathan Yong65%
$30 → $27MaintainsNeutralGet Alert
03/06/2023Buy Now416.13%Canaccord Genuity
Richard Close43%
$40 → $36MaintainsBuyGet Alert
03/06/2023Buy Now229.75%Wells Fargo
Stan Berenshteyn41%
$28 → $23MaintainsEqual-WeightGet Alert
02/28/2023Buy Now330.11%Citigroup
Daniel Grosslight39%
$33 → $30MaintainsNeutralGet Alert
02/27/2023Buy Now287.1%Deutsche Bank
George Hill61%
$31 → $27MaintainsHoldGet Alert
02/27/2023Buy Now373.12%JP Morgan
Lisa Gill56%
$35 → $33MaintainsNeutralGet Alert
02/23/2023Buy Now401.79%Oppenheimer
Michael Wiederhorn60%
$37 → $35MaintainsOutperformGet Alert
02/23/2023Buy Now401.79%RBC Capital
Sean Dodge46%
→ $35Reiterates → OutperformGet Alert
02/23/2023Buy Now387.46%SVB Leerink
Stephanie Davis39%
→ $34UpgradeMarket Perform → OutperformGet Alert
01/19/2023Buy Now430.47%Oppenheimer
Colin Rusch58%
$45 → $37MaintainsOutperformGet Alert
01/18/2023Buy Now301.43%Barclays
Marc Solecitto60%
$32 → $28MaintainsEqual-WeightGet Alert
12/13/2022Buy Now373.12%Citigroup
Daniel Grosslight39%
$36 → $33MaintainsNeutralGet Alert
10/31/2022Buy Now330.11%Credit Suisse
Jonathan Yong65%
$35 → $30MaintainsNeutralGet Alert
10/27/2022Buy Now416.13%Citigroup
Daniel Grosslight39%
$38 → $36MaintainsNeutralGet Alert
10/27/2022Buy Now358.78%Barclays
Steve Valiquette53%
$33 → $32MaintainsEqual-WeightGet Alert
10/25/2022Buy Now473.48%DA Davidson
Robert Simmons52%
$45 → $40MaintainsBuyGet Alert
10/24/2022Buy NowGuggenheim
Sandy Draper73%
UpgradeSell → NeutralGet Alert
10/21/2022Buy Now315.77%Truist Securities
Jailendra Singh34%
$35 → $29MaintainsHoldGet Alert
10/11/2022Buy Now373.12%Barclays
Steve Valiquette53%
$40 → $33MaintainsEqual-WeightGet Alert
09/28/2022Buy Now401.79%RBC Capital
Sean Dodge46%
$53 → $35MaintainsOutperformGet Alert
09/27/2022Buy Now344.44%Deutsche Bank
George Hill61%
$34 → $31MaintainsHoldGet Alert

FAQ

Q

What is the target price for Teladoc Health (TDOC) stock?

A

The latest price target for Teladoc Health (NYSE:TDOC) was reported by B of A Securities on May 28, 2025. The analyst firm set a price target for $7.00 expecting TDOC to rise to within 12 months (a possible 0.36% upside). 41 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Teladoc Health (TDOC)?

A

The latest analyst rating for Teladoc Health (NYSE:TDOC) was provided by B of A Securities, and Teladoc Health maintained their neutral rating.

Q

When was the last upgrade for Teladoc Health (TDOC)?

A

The last upgrade for Teladoc Health Inc happened on February 23, 2023 when SVB Leerink raised their price target to $34. SVB Leerink previously had a market perform for Teladoc Health Inc.

Q

When was the last downgrade for Teladoc Health (TDOC)?

A

There is no last downgrade for Teladoc Health.

Q

When is the next analyst rating going to be posted or updated for Teladoc Health (TDOC)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Teladoc Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Teladoc Health was filed on May 28, 2025 so you should expect the next rating to be made available sometime around May 28, 2026.

Q

Is the Analyst Rating Teladoc Health (TDOC) correct?

A

While ratings are subjective and will change, the latest Teladoc Health (TDOC) rating was a maintained with a price target of $8.00 to $7.00. The current price Teladoc Health (TDOC) is trading at is $6.98, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch